Home ›
Entities
› academia
› Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Research article (Leukemia, 2020) · cited 129× · AI/ML
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Summary
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making is a scholarly article[1].
Key Facts
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Retrieved May 24, 2026, from https://4ort.xyz/entity/validation-of-nomogram-revised-risk-index-and-comparison-with-other-models-for-extranodal-nasal-type-nk-t-cell-lymphoma-
MLA“Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/validation-of-nomogram-revised-risk-index-and-comparison-with-other-models-for-extranodal-nasal-type-nk-t-cell-lymphoma-.
BibTeX@misc{4ortxyz_validation-of-nomogram-revised-risk-index-and-comparison-with-other-models-for-extranodal-nasal-type-nk-t-cell-lymphoma-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making}}, year = {2026}, url = {https://4ort.xyz/entity/validation-of-nomogram-revised-risk-index-and-comparison-with-other-models-for-extranodal-nasal-type-nk-t-cell-lymphoma-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making — https://4ort.xyz/entity/validation-of-nomogram-revised-risk-index-and-comparison-with-other-models-for-extranodal-nasal-type-nk-t-cell-lymphoma- (retrieved 2026-05-24)
